Decentro Raises INR 30 Cr in Series B Round to Strengthen Financial Infrastructure
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Y Combinator-backed fintech startup Decentro has raised INR 30 crore in its Series B funding round led by InfoEdge Ventures, with participation from Stargazer Growth (backed by Groww CEO Lalit Keshre) and existing investor Uncorrelated Ventures.
The funds will be deployed to enhance enterprise adoption, scale product capabilities, and expand go-to-market initiatives across financial institutions, including banks, NBFCs, digital lenders, and fintech platforms. The investment underscores Decentro's mission to become India's operating system for financial infrastructure.
"Our goal has always been to make financial and banking infrastructure simple, secure, and reliable at scale," said Rohit Taneja, Co-founder and CEO of Decentro. "This fundraise allows us to double down on what's working—deep partnerships with enterprise customers and products that power mission-critical financial flows."
Founded in 2020 by Rohit Taneja and Pratik Daudkhane, Decentro offers a comprehensive API banking platform that enables consumer and business verification, payment collections and disbursals, and AI-powered debt recovery.
The startup claims to process INR 50,000 crore annually in payment volumes and serve over 1,300 businesses.
Recent product innovations include:
Scanner : A real-time user profiling and risk assessment engine used across BFSI and e-commerce sectors.
: A real-time user profiling and risk assessment engine used across BFSI and e-commerce sectors. Neobot: India's first multilingual AI voice agent for automated debt collections, tackling the nation's INR 10+ lakh crore NPA problem.
Payments remain Decentro's largest revenue driver, with its AI products witnessing rapid adoption.
Signaling its long-term commitment to India, Decentro announced plans to relocate its parent entity from Singapore to India within the next 12–18 months. "This flip is a strong statement of our belief in India's capacity to foster and scale global financial infrastructure companies," said Daudkhane.
The Series B round not only strengthens Decentro's position in India's fintech landscape but also reinforces the emerging investor confidence in infrastructure-first fintech startups—those powering the backend rather than competing for front-end consumer attention.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan
ZimVie Inc. (NASDAQ:ZIMV) is one of the best undervalued medical device stocks to buy now. On June 5, ZimVie Inc. (NASDAQ:ZIMV) announced the launch of its RealGUIDE Software Suite and Implant Concierge service in Japan. A medical professional working on a dental implant in an operating room. The launch of the service in the Japenese market provides dentists expanded access to a digital dental implant ecosystem that extends from implant planning to placement and offers vertically integrated, end-to-end solutions. Management reported that the dental implant market opportunity is significant in Japan, and the country is ZimVie Inc.'s (NASDAQ:ZIMV) largest market in the APAC region. RealGUIDE software is the first complete cloud-based solution of its kind, and offers dentists all they need for precise implant planning, restorative design, and surgical guides to deliver time, workflow, and cost efficiencies. Implant Concierge is a virtual outsourcing service that aims to simplify and streamline guided surgery and implant treatment planning. ZimVie Inc. (NASDAQ:ZIMV) manufactures, designs, and distributes medical devices and surgical instruments. The company's operations are divided into the Spine Products and Dental Products segments. While we acknowledge the potential of ZIMV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Piper sees H20 ban hurting Nvidia sales by $8B in July quarter
Piper Sandler keeps an Overweight rating on Nvidia (NVDA) after the company said it expects to be granted licenses to resume H20 chip sales to China. During the April quarter, the company posted $4.6B in sales for H20 and left an additional $2.5B on the table due to the ban, the analyst tells investors in a research note. Piper says the estimated impact from the ban in the July quarter was around $8B in sales. It suspects strong demand for these chips would have continued should the ban not been in place. The merchant artificial intelligence companies alongside Nvidia, namely Micron (MU) and AMD (AMD), would benefit from the lifting of this ban, contends Piper. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on NVDA: Disclaimer & DisclosureReport an Issue Nvidia price target raised to $195 from $160 at DZ Bank Notable open interest changes for July 15th Video: Nvidia, AMD jump as shipments to China expected to resume Eaton, Nvidia collaborate on power infrastructure in artificial intelligence Nvidia price target raised to $235 from $205 at Melius Research Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on WeRide (WRD), Sets a $13 PT
WeRide Inc. (NASDAQ:WRD) is one of the best oversold NASDAQ stocks to buy now. Analyst Tim Hsiao from Morgan Stanley maintained a Buy rating on WeRide Inc. (NASDAQ:WRD) on May 22 and set a $13.00 price target. A pick-up and delivery truck speeding down a busy city street. The analyst based the rating on the company's potential in the autonomous vehicle market, maintaining an optimistic outlook on its long-term prospects despite near-term uncertainties in the robosweeper and robobus sectors. The analyst is particularly optimistic about the robotaxi segment, stating that WeRide Inc.'s (NASDAQ:WRD) continued expansion in China and recent project breakthroughs with Uber position it well to capitalize on its first-mover advantage in Level 4 autonomous driving. While Hsiao acknowledged that WeRide Inc. (NASDAQ:WRD) may see share price volatility in the short term, he stated that he sees considerable upside potential, especially as the focus of the market moves back to robotaxis. The firm reasoned that the unchanged expectations for robotaxis and the expected breakeven in 2027 further support the constructive rating. WeRide Inc. (NASDAQ:WRD) is headquartered in Guangzhou, China, and develops an autonomous driving technology platform. The company offers Robotaxi, Robobus, Robovan, Robosweeper, and advanced driving solutions. Its offerings also include smart services in online ride-hailing, environmental sanitation, on-demand transport, and urban logistics. While we acknowledge the potential of WRD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
